Financial insights of MDAIW

MyFinsight

Income Statement	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Research and development revenue	3,991	6,365*	3,792	5,065
Cost of revenue	1,964	3,306*	2,171	2,775
Gross profit	2,027	3,059*	1,621	2,290
General and administrative	3,998	3,466	4,962	4,413
Total operating costs and expenses	3,998	3,466*	4,962	4,413
Operating loss	-1,971	-407*	-3,341	-2,123
Other income (expenses), including transactions costs	NaN	NaN	NaN	0
Net interest (expense) income	258	-14*	300	NaN
Change in fair value of notes payable	NaN	-220*	NaN	0
Financing related costs	7	263*	NaN	NaN
Borrowing related costs	NaN	NaN	164	124
Amortization of debt discount	179	114*	NaN	NaN
Net interest (expense) income	NaN	NaN	NaN	-277
Change in fair value of warrant liability	1,002	-10,296*	-264	5,449
Foreign exchange transaction gain, net	-5	1*	-9	-14
Total other income (expense), net	-1,451	10,154*	-209	-5,864
Income (gain) before income taxes	-3,422	9,747*	-3,550	-7,987
Income tax provision	-10	37*	2	-19
Net income (gain)	-3,412	9,710*	-3,552	-7,968
Foreign currency translation adjustments	-10	9*	-13	32
Total comprehensive income (gain)	-3,422	9,718	-3,565	-7,936

Basic EPS	-0.11	0.349	-0.13	-0.31
Diluted EPS	-0.11	0.349	-0.13	-0.31
Basic Average Shares	31,756,649	27,815,244	26,318,624	25,421,560
Diluted Average Shares	31,756,649	27,815,244	26,318,624	25,421,560

Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.